e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
IIPs: orphan
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)?
Ilaria Campo (Pavia, Italy), Ilaria Campo, Michele Zorzetto, Francesco Bonella, Francesca Mariani, Elena Paracchini, Simona Ferrari, Francesca Datturi, Federica Meloni, Maurizio Luisetti
Source:
International Congress 2015 – IIPs: orphan
Session:
IIPs: orphan
Session type:
Thematic Poster Session
Number:
3812
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ilaria Campo (Pavia, Italy), Ilaria Campo, Michele Zorzetto, Francesco Bonella, Francesca Mariani, Elena Paracchini, Simona Ferrari, Francesca Datturi, Federica Meloni, Maurizio Luisetti. Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)?. Eur Respir J 2015; 46: Suppl. 59, 3812
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Lane-hamilton syndrome and CCF: a fatal association
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume?
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP)
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP)
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL)
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001
A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP).
Source: International Congress 2017 – Novel and old entities
Year: 2017
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP).
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Difference in the dynamic state between SP-A and SP-D in the IPF lung
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Diagnosing Interstitial lung disease. The value of BAL and (cryo)biopsy
Source: ERS Course: Interventional bronchoscopy
Year: 2019
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Transbronchial cryobiopsy for the diagnosis of interstitial lung disease (ILD) – The UK experience
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept